Soros Fund Management’s PharMerica Corporation PMC Stock Holding History

Soros Fund Management’s Portfolio PMC Stock Details PMC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-100,129	Closed	-$2.21M	–	282
2016 Q1	$2.21M	Buy	+100,129	New	+$2.66M	0.05%	131

Other funds holding PMC

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Soros Fund Management's PMC Position: Q2 2016 in Review

Soros Fund Management sold out of PharMerica Corporation (PMC) in Q2 2016, closing a stake of 100,129 shares — an estimated $2.21M sold.

Soros Fund Management first reported a position in PMC in Q1 2016 and held it in 1 quarter. The position peaked at $2.21M in Q1 2016. 174 funds tracked by Wall St. Rank hold PMC as of Q2 2016.

Soros Fund Management reported no remaining PharMerica Corporation position as of Q2 2016 after selling out during the quarter.
Soros Fund Management sold 100,129 PharMerica Corporation shares in Q2 2016, an estimated $2.21M.
Soros Fund Management first reported a position in PharMerica Corporation in Q1 2016 and held it in 1 quarter.
Soros Fund Management's PharMerica Corporation position peaked at $2.21M in Q1 2016.
174 funds tracked by Wall St. Rank held PharMerica Corporation as of Q2 2016.

Based on Soros Fund Management's 13F filing for Q2 2016, filed 15 Aug 2016.